Company Analysis

Becton, Dickinson and Co. (BDX)

NYSE: BDX · Surgical & Medical Instruments & Apparatus · Franklin Lakes, NJ · filing with the SEC since 1994
Grade5.5
◀ Past 6.7● Present 5.8▶ Future 3.8
The companyfiscal 2025, as filed
Revenue$21.84B+8.2%
Net income$1.68B-1.6%
Earnings per share$5.82-0.7%
Operating cash flow$3.43B-10.8%
Cash$641M-62.7%
Debt$17.62B-1.8%
Shareholders’ equity$25.39B-1.9%
Shares, diluted288.5M-0.9%
Return on equity6.6%
The recordfrom its filings
Filings in 2026118
Newest filingNov 10 · 144
Annual reportNov 25, 2025
Quarterly reportAug 6, 2026
Next report due10-K by Nov 29
Insider sales, 12 months$3.4M
Insider buys, 12 months$0.00
Patents granted10,762
Filer categoryLarge accelerated filer
Trailing twelve months to Jun 2026Revenue $23.25BNet income $941Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
16171819202122232425
As filed, in USD. Nothing here is a forecast.

News

Nov 10, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 10, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 9, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Nov 5, 2026 · SEC EDGAR · Form 8-K
Results released
Open the filing on sec.gov
Oct 27, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Sep 29, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton BDX · research, not advice